Search Within

Jorg Cammenga

Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (15)
  2. Hematologic Malignancies, Division of (15)
  3. Sloan Kettering Institute Faculty (6)
  4. Cell Biology Program Faculty (5)
  5. Developmental Biology Program Faculty (1)
People
  1. Stephen Nimer (15)
  2. James Mulloy (9)
  3. Francisco Berguido (7)
  4. Malcolm Moore (5)
  5. Karen Mackenzie (3)
  6. Agnes Viale (2)

More People

Years
  1. 2005 (2)
  2. 2003 (2)
  3. 2002 (4)
  4. 2001 (4)
  5. 2000 (3)
  6. 1999 (1)
Publications
  1. Blood (10)
  2. Current Oncology Reports (1)
  3. Experimental Hematology (1)
  4. Leukemia Research (1)
  5. Oncogene (1)
  6. Pflügers Archiv - European Journal of Physiology (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Springer (2)
  3. Elsevier Ltd (1)
  4. Elsevier Science, Inc. (1)
  5. National Academy of Sciences (1)
  6. Nature Publishing Group (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate
    Journal Article

    Cammenga, J.; Horn, S.; Bergholz, U.; Sommer, G.; Besmer, P.; Fiedler, W.; Stocking, C.
    Blood (2005)

    Fulltext@MSK | Save
  • AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion
    Journal Article

    Mulloy, J. C.; Jankovic, V.; Wunderlich, M.; Delwel, R.; Cammenga, J.; Krejci, O.; Zhao, H.; Valk, P. J. M.; Löwenberg, B.; Nimer, S. D.
    Proceedings of the National Academy of Sciences of the United States of America (2005)

    Fulltext@MSK | Save
  • Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
    Journal Article

    Mulloy, J. C.; Cammenga, J.; Berguido, F. J.; Wu, K.; Zhou, P.; Comenzo, R. L.; Jhanwar, S.; Moore, M. A. S.; Nimer, S. D.
    Blood (2003)

    Fulltext@MSK | Save
  • Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells
    Journal Article

    Cammenga, J.; Mulloy, J. C.; Berguido, F. J.; Macgrogan, D.; Viale, A.; Nimer, S. D.
    Blood (2003)

    Fulltext@MSK | Save
  • TrkA is a downstream target of AML1-ETO and promotes leukemic stem cell self-renewal
    Meeting Abstract

    Mulloy, J. C.; Cammenga, J.; Wu, K.; Zhou, P.; Comenzo, R. L.; Moore, M. A. S.; Berguido, F. J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Transcription factor fusions in acute leukemia: Variations on a theme
    Journal Article

    Scandura, J. M.; Boccuni, P.; Cammenga, J.; Nimer, S. D.
    Oncogene (2002)

    Fulltext@MSK | Save
  • Mutations in human cancer: How close should we look?
    Journal Article

    Cammenga, J.; Nimer, S. D.
    Leukemia Research (2002)

    Fulltext@MSK | Save
  • The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
    Journal Article

    Mulloy, J. C.; Cammenga, J.; Mackenzie, K. L.; Berguido, F. J.; Moore, M. A. S.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • The AML1/ETO fusion protein promotes the expansion of human hematopoietic stem cells
    Meeting Abstract

    Mulloy, J. C.; Cammenga, J.; Mackenzie, K. L.; Moore, M. A. S.; Nimer, S. D.
    Experimental Hematology (2001)

    Fulltext@MSK | Save
  • Identification and characterization of AML1/ETO target genes in primary human CD34+cells
    Meeting Abstract

    Cammenga, J.; Mulloy, J. C.; Berguido, F. J.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save